NeueHealth, Inc.
0.00%
0
1671284
10920V404
Oct 1, 2025
Oct 6, 2025, 05:00 PM
Reporting Persons (12)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| StepStone Group LP | Partnership | 0.00% | 0 | 0 | 0 |
| StepStone VC Global Partners VII, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| StepStone VC Global Partners VII-B, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| StepStone VC Global Partners VII-D, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| StepStone VC Global Partners VII-S, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| StepStone VC Opportunities IV, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| StepStone Master G, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| AU Special Investments, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| StepStone VC Opportunities VI, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| StepStone VC Opportunities VI-D, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| StepStone VC Opportunities V, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| StepStone Opportunities V-D, L.P. | Partnership | 0.00% | 0 | 0 | 0 |
Disclosure Items (2)
Common Stock, par value $0.0001 per share
NeueHealth, Inc.
9250 NW 36th St, Doral, FL, 33178
Item 5 of the Schedule 13D is amended and supplemented as follows: The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference.
The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated by reference.
Except for the information set forth in Item 5(e) hereof, which is incorporated by reference, none of the Reporting Persons has effected any transaction in the Common Stock during the last 60 days.
On October 2, 2025, all of the shares of Common Stock held by the Reporting Persons were canceled and extinguished and automatically converted into the right to receive cash in an amount equal to $7.33 per share in connection with the Issuer's previously announced business combination. As a result, each of the Reporting Persons ceased to be the beneficial owner of more than five percent of the Common Stock.